197 related articles for article (PubMed ID: 23602568)
1. The protein interaction landscape of the human CMGC kinase group.
Varjosalo M; Keskitalo S; Van Drogen A; Nurkkala H; Vichalkovski A; Aebersold R; Gstaiger M
Cell Rep; 2013 Apr; 3(4):1306-20. PubMed ID: 23602568
[TBL] [Abstract][Full Text] [Related]
2. Analysis of cell growth inhibitory effects of catechin through MAPK in human breast cancer cell line T47D.
Deguchi H; Fujii T; Nakagawa S; Koga T; Shirouzu K
Int J Oncol; 2002 Dec; 21(6):1301-5. PubMed ID: 12429981
[TBL] [Abstract][Full Text] [Related]
3. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.
Lenferink AE; Busse D; Flanagan WM; Yakes FM; Arteaga CL
Cancer Res; 2001 Sep; 61(17):6583-91. PubMed ID: 11522658
[TBL] [Abstract][Full Text] [Related]
4. Evolutionary constraints associated with functional specificity of the CMGC protein kinases MAPK, CDK, GSK, SRPK, DYRK, and CK2alpha.
Kannan N; Neuwald AF
Protein Sci; 2004 Aug; 13(8):2059-77. PubMed ID: 15273306
[TBL] [Abstract][Full Text] [Related]
5. Signalling specificity of Ser/Thr protein kinases through docking-site-mediated interactions.
Biondi RM; Nebreda AR
Biochem J; 2003 May; 372(Pt 1):1-13. PubMed ID: 12600273
[TBL] [Abstract][Full Text] [Related]
6. Induction of down-regulation of the kinase activities of Mek, p42Erk, p90RSK, and p63SAMK in chicken embryo fibroblast at the late stage of src-induced cellular transformation.
Wang HC
J Cell Physiol; 1996 Jul; 168(1):87-96. PubMed ID: 8647927
[TBL] [Abstract][Full Text] [Related]
7. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS
Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of dual specificity kinase activity of DYRK1A.
Walte A; Rüben K; Birner-Gruenberger R; Preisinger C; Bamberg-Lemper S; Hilz N; Bracher F; Becker W
FEBS J; 2013 Sep; 280(18):4495-511. PubMed ID: 23809146
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-2 activation of STAT5 requires the convergent action of tyrosine kinases and a serine/threonine kinase pathway distinct from the Raf1/ERK2 MAP kinase pathway.
Beadling C; Ng J; Babbage JW; Cantrell DA
EMBO J; 1996 Apr; 15(8):1902-13. PubMed ID: 8617237
[TBL] [Abstract][Full Text] [Related]
10. Control of MAP kinase activation by the mitogen-induced threonine/tyrosine phosphatase PAC1.
Ward Y; Gupta S; Jensen P; Wartmann M; Davis RJ; Kelly K
Nature; 1994 Feb; 367(6464):651-4. PubMed ID: 8107850
[TBL] [Abstract][Full Text] [Related]
11. Catalytic activation of mitogen-activated protein (MAP) kinase phosphatase-1 by binding to p38 MAP kinase: critical role of the p38 C-terminal domain in its negative regulation.
Hutter D; Chen P; Barnes J; Liu Y
Biochem J; 2000 Nov; 352 Pt 1(Pt 1):155-63. PubMed ID: 11062068
[TBL] [Abstract][Full Text] [Related]
12. Interaction of the insulin receptor kinase with serine/threonine kinases in vitro.
Haring HU; White MF; Kahn CR; Ahmad Z; DePaoli-Roach AA; Roach PJ
J Cell Biochem; 1985; 28(2):171-82. PubMed ID: 3001107
[TBL] [Abstract][Full Text] [Related]
13. PhosphoPICK: modelling cellular context to map kinase-substrate phosphorylation events.
Patrick R; Lê Cao KA; Kobe B; Bodén M
Bioinformatics; 2015 Feb; 31(3):382-9. PubMed ID: 25304781
[TBL] [Abstract][Full Text] [Related]
14. CMGC Kinases in Health and Cancer.
Chowdhury I; Dashi G; Keskitalo S
Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568654
[TBL] [Abstract][Full Text] [Related]
15. Interplay Between CMGC Kinases Targeting SR Proteins and Viral Replication: Splicing and Beyond.
Pastor F; Shkreta L; Chabot B; Durantel D; Salvetti A
Front Microbiol; 2021; 12():658721. PubMed ID: 33854493
[TBL] [Abstract][Full Text] [Related]
16. PSEA: Kinase-specific prediction and analysis of human phosphorylation substrates.
Suo SB; Qiu JD; Shi SP; Chen X; Liang RP
Sci Rep; 2014 Mar; 4():4524. PubMed ID: 24681538
[TBL] [Abstract][Full Text] [Related]
17. Multi-layered proteomic analyses decode compositional and functional effects of cancer mutations on kinase complexes.
Mehnert M; Ciuffa R; Frommelt F; Uliana F; van Drogen A; Ruminski K; Gstaiger M; Aebersold R
Nat Commun; 2020 Jul; 11(1):3563. PubMed ID: 32678104
[TBL] [Abstract][Full Text] [Related]
18. Mapping global protein contacts.
Vajda S; Emili A
Science; 2019 Jul; 365(6449):120-121. PubMed ID: 31296755
[No Abstract] [Full Text] [Related]
19. A proteome-scale map of the human interactome network.
Rolland T; Taşan M; Charloteaux B; Pevzner SJ; Zhong Q; Sahni N; Yi S; Lemmens I; Fontanillo C; Mosca R; Kamburov A; Ghiassian SD; Yang X; Ghamsari L; Balcha D; Begg BE; Braun P; Brehme M; Broly MP; Carvunis AR; Convery-Zupan D; Corominas R; Coulombe-Huntington J; Dann E; Dreze M; Dricot A; Fan C; Franzosa E; Gebreab F; Gutierrez BJ; Hardy MF; Jin M; Kang S; Kiros R; Lin GN; Luck K; MacWilliams A; Menche J; Murray RR; Palagi A; Poulin MM; Rambout X; Rasla J; Reichert P; Romero V; Ruyssinck E; Sahalie JM; Scholz A; Shah AA; Sharma A; Shen Y; Spirohn K; Tam S; Tejeda AO; Wanamaker SA; Twizere JC; Vega K; Walsh J; Cusick ME; Xia Y; Barabási AL; Iakoucheva LM; Aloy P; De Las Rivas J; Tavernier J; Calderwood MA; Hill DE; Hao T; Roth FP; Vidal M
Cell; 2014 Nov; 159(5):1212-1226. PubMed ID: 25416956
[TBL] [Abstract][Full Text] [Related]
20. The BioPlex Network: A Systematic Exploration of the Human Interactome.
Huttlin EL; Ting L; Bruckner RJ; Gebreab F; Gygi MP; Szpyt J; Tam S; Zarraga G; Colby G; Baltier K; Dong R; Guarani V; Vaites LP; Ordureau A; Rad R; Erickson BK; Wühr M; Chick J; Zhai B; Kolippakkam D; Mintseris J; Obar RA; Harris T; Artavanis-Tsakonas S; Sowa ME; De Camilli P; Paulo JA; Harper JW; Gygi SP
Cell; 2015 Jul; 162(2):425-440. PubMed ID: 26186194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
